Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 MG budesonide effervescent tablet FOR orodispersible USE
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
21 MG budesonide effervescent tablet FOR orodispersible USE
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31MG budesonide effervescent tablet FOR orodispersible USE
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42MG budesonide effervescent tablet FOR orodispersible USE
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
5Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 66, 93, 94, 95, 96, 97, 98 💬
6Budesonide 0.5 MG compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
7Budesonide 0.5 MG orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
8Budesonide 0.5MG orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
9Budesonide 1 MG compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
10Budesonide 1 MG orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
11Budesonide 1MG orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
12Budesonide [0.4MG/ML] viscous suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
13Budesonide GEL
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
14Budesonide MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
15Budesonide MMX 6 MG tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
16Budesonide MMX® 6 MG
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
17Budesonide MMX® 9 MG
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
18Budesonide oral suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
19Budesonide plus prevacid
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
20Budesonide-formoterol single inhaler
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
21Budesonide-MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
22Budesonide-MMX® 6 MG
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
23Budesonide-MMX® 9 MG
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
24Budesonide/formoterol
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 228 💬
25Combination oral budesonide and rectal hydrocortisone
(D00246)		----[1] 97 💬
26Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
27Compressa effervescente 1 MG DI budesonide PER USO orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
28Formoterol/budesonide
(D00246)		[1] Formoterol[2] Formoterol fumarate ,
Formoterol 💬 		[1] ADRB2 💬 [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
29GUT-directed budesonide and SOC
(D00246)		----[1] 66 💬
30High dose budesonide
(D00246)		----[1] 97 💬
31High dose budesonide rectal foam
(D00246)		----[1] 97 💬
32High dose budesonide suspension
(D00246)		----[1] 98 💬
33High dose budesonide tablet
(D00246)		----[1] 98 💬
34High dose OF budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
35Inhaled/swallowed budesonide
(D00246)		----[1] 98 💬
36LOW dose budesonide
(D00246)		----[1] 97 💬
37LOW dose budesonide rectal foam
(D00246)		----[1] 97 💬
38LOW dose budesonide tablet
(D00246)		----[1] 98 💬
39Methylprednisolone or budesonide
(D00246)		[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
40Oral budesonide
(D00246)		----[2] 97, 98 💬
41Oral viscous budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42Probiotics combined with enteric-coated budesonide capsule
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
43Viscous/swallowed budesonide
(D00246)		----[1] 98 💬